ATX
Click for more information
3.28% 6.3¢ amplia therapeutics limited

Good question It does say in the announcement … The proposed...

  1. optimistic punter
    2,130 Posts.
    lightbulb Created with Sketch. 668
    clock Created with Sketch.
    29/02/24
    12:17
    Post #: 72667966
    Good question

    It does say in the announcement …

    The proposed trial will explore the safety, tolerability and efficacy of a combination of narmafotinib with the chemotherapy regime FOLFIRINOX.

    So Presumably not … as the wording says, explore safety tolerability and efficacy


    As we know efficacy was not officially tested in the Australian phase 1b trail …

    .
    ATX Price at posting: 7.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

EMD Emyria and UWA secure $499,411 grant to advance MDMA analogue drug program
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
NEWS Has uranium run out of steam? An update on nuclear markets & developments ahead in FY25
right-arrow Created with Sketch.
LLL Leo Lithium announces major divestment of flagship Goulamina project to Ganfeng
right-arrow Created with Sketch.
ITM iTech lifts MRE at Eyre Peninsula Graphite Project by 300%
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.3¢ 		Change
0.002(3.28%) 		Mkt cap ! $17.11M
Open High Low Value Volume
6.2¢ 6.5¢ 6.1¢ $49.07K 778.9K

Buyers (Bids)

No. Vol. Price($)
1 1994 6.2¢
 

Sellers (Offers)

Price($) Vol. No.
6.3¢ 7737 1
View Market Depth
Last trade - 12.11pm 03/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.